[
  {
    "ts": null,
    "headline": "Boston Scientific Corp. stock rises Thursday, still underperforms market",
    "summary": "Boston Scientific Corp. stock rises Thursday, still underperforms market",
    "url": "https://finnhub.io/api/news?id=bacbe29480056f63f537eb843178bf0bc37ffbed2d3fc519c4f2adb9375eb337",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1730997660,
      "headline": "Boston Scientific Corp. stock rises Thursday, still underperforms market",
      "id": 131193338,
      "image": "",
      "related": "BSX",
      "source": "MarketWatch",
      "summary": "Boston Scientific Corp. stock rises Thursday, still underperforms market",
      "url": "https://finnhub.io/api/news?id=bacbe29480056f63f537eb843178bf0bc37ffbed2d3fc519c4f2adb9375eb337"
    }
  },
  {
    "ts": null,
    "headline": "CLOV Stock Declines Despite Q3 Earnings Beat, FY24 View Revised",
    "summary": "Clover Health's third-quarter 2024 results continue to benefit from the strength of its business model.",
    "url": "https://finnhub.io/api/news?id=67c185b3f1212393865e41c792dafc3c8feab0093928485a43f4a9cf3aaee5b3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1730996280,
      "headline": "CLOV Stock Declines Despite Q3 Earnings Beat, FY24 View Revised",
      "id": 131169700,
      "image": "https://media.zenfs.com/en/zacks.com/f4f040597ee01c61420a977a95c5b391",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Clover Health's third-quarter 2024 results continue to benefit from the strength of its business model.",
      "url": "https://finnhub.io/api/news?id=67c185b3f1212393865e41c792dafc3c8feab0093928485a43f4a9cf3aaee5b3"
    }
  },
  {
    "ts": null,
    "headline": "Veracyte Q3 Earnings Beat Estimates, 2024 Guidance Raised",
    "summary": "VCYT registers robust growth from its market-leading Decipher Prostate and Afirma tests.",
    "url": "https://finnhub.io/api/news?id=c43ba7fe869e2b20c515dc73b10d39c7831c1d06dbc5c0afa9ea833b2a6812d1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1730994720,
      "headline": "Veracyte Q3 Earnings Beat Estimates, 2024 Guidance Raised",
      "id": 131165190,
      "image": "https://media.zenfs.com/en/zacks.com/51f0c2cd09522c9a15cba48260e4facf",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "VCYT registers robust growth from its market-leading Decipher Prostate and Afirma tests.",
      "url": "https://finnhub.io/api/news?id=c43ba7fe869e2b20c515dc73b10d39c7831c1d06dbc5c0afa9ea833b2a6812d1"
    }
  },
  {
    "ts": null,
    "headline": "BDX Stock Gains Following Q4 Earnings Beat and Higher Margins",
    "summary": "BD's overall topline in the fourth quarter of fiscal 2024 benefits from revenue growth in all segments.",
    "url": "https://finnhub.io/api/news?id=c30b111b955aa5e0ca8c030ab243c15be69818149aa98797741e266e1c56ca8d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1730993520,
      "headline": "BDX Stock Gains Following Q4 Earnings Beat and Higher Margins",
      "id": 131169704,
      "image": "https://media.zenfs.com/en/zacks.com/51f0c2cd09522c9a15cba48260e4facf",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "BD's overall topline in the fourth quarter of fiscal 2024 benefits from revenue growth in all segments.",
      "url": "https://finnhub.io/api/news?id=c30b111b955aa5e0ca8c030ab243c15be69818149aa98797741e266e1c56ca8d"
    }
  },
  {
    "ts": null,
    "headline": "QIAGEN Stock Flat Post Q3 Earnings & Revenue Beat, 2024 EPS View Up",
    "summary": "QGEN delivers another solid performance in the third quarter of 2024, with both the top and bottom lines surpassing estimates.",
    "url": "https://finnhub.io/api/news?id=09c69d2402d4e2b2e303a5de116cb34976196c7a986df057250403fc3239f045",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1730992860,
      "headline": "QIAGEN Stock Flat Post Q3 Earnings & Revenue Beat, 2024 EPS View Up",
      "id": 131164963,
      "image": "https://media.zenfs.com/en/zacks.com/51f0c2cd09522c9a15cba48260e4facf",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "QGEN delivers another solid performance in the third quarter of 2024, with both the top and bottom lines surpassing estimates.",
      "url": "https://finnhub.io/api/news?id=09c69d2402d4e2b2e303a5de116cb34976196c7a986df057250403fc3239f045"
    }
  },
  {
    "ts": null,
    "headline": "Phibro's Q1 Earnings Top Estimates, Stock Up, Net Sales Surge Y/Y",
    "summary": "PAHC delivers strong growth across all its segments in the first quarter of fiscal 2025.",
    "url": "https://finnhub.io/api/news?id=a99a395e260a9386de1a0ce784aaba17985dba70e0e57d15f9c6631694d9161b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1730986140,
      "headline": "Phibro's Q1 Earnings Top Estimates, Stock Up, Net Sales Surge Y/Y",
      "id": 131156738,
      "image": "https://media.zenfs.com/en/zacks.com/0e6e00119767dea571e2db52c929df03",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "PAHC delivers strong growth across all its segments in the first quarter of fiscal 2025.",
      "url": "https://finnhub.io/api/news?id=a99a395e260a9386de1a0ce784aaba17985dba70e0e57d15f9c6631694d9161b"
    }
  },
  {
    "ts": null,
    "headline": "J&J wins FDA approval for Varipulse PFA system",
    "summary": "J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing rapid adoption.",
    "url": "https://finnhub.io/api/news?id=9c751d072d423b75038f5df7aa4549475c30e7cec0f537d95fc5ccf32e80ebec",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1730979352,
      "headline": "J&J wins FDA approval for Varipulse PFA system",
      "id": 131168039,
      "image": "https://imgproxy.divecdn.com/OGoIFwIwJ-BG__zRNyfTJAtMYRgdIuQp_PYWmW082g4/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9WQVJJUFVMU0VfMjVtbV9Mb29wX0FuZ2xlX1ZpZXdfMS53ZWJw.webp",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing rapid adoption.",
      "url": "https://finnhub.io/api/news?id=9c751d072d423b75038f5df7aa4549475c30e7cec0f537d95fc5ccf32e80ebec"
    }
  }
]